作者
David K Cole, Anna M Bulek, Garry Dolton, Andrea J Schauenberg, Barbara Szomolay, William Rittase, Andrew Trimby, Prithiviraj Jothikumar, Anna Fuller, Ania Skowera, Jamie Rossjohn, Cheng Zhu, John J Miles, Mark Peakman, Linda Wooldridge, Pierre J Rizkallah, Andrew K Sewell
发表日期
2016/6/1
期刊
The Journal of clinical investigation
卷号
126
期号
6
页码范围
2191-2204
出版商
American Society for Clinical Investigation
简介
The cross-reactivity of T cells with pathogen- and self-derived peptides has been implicated as a pathway involved in the development of autoimmunity. However, the mechanisms that allow the clonal T cell antigen receptor (TCR) to functionally engage multiple peptide–major histocompatibility complexes (pMHC) are unclear. Here, we studied multiligand discrimination by a human, preproinsulin reactive, MHC class-I–restricted CD8+ T cell clone (1E6) that can recognize over 1 million different peptides. We generated high-resolution structures of the 1E6 TCR bound to 7 altered peptide ligands, including a pathogen-derived peptide that was an order of magnitude more potent than the natural self-peptide. Evaluation of these structures demonstrated that binding was stabilized through a conserved lock-and-key–like minimal binding footprint that enables 1E6 TCR to tolerate vast numbers of substitutions outside of …
引用总数
20162017201820192020202120222023202482119142520272310
学术搜索中的文章